{"schema_version":"secwatch.filing_event.v1","accession":"0001005286-24-000056","form_type":"8-K","ticker":"LFCR","cik":"0001005286","company_name":"LIFECORE BIOMEDICAL, INC. DE","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.832522+00:00","generated_at":"2026-06-02T15:17:01.744039+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Lifecore changes executive incentive from cash to stock for FY2024","bullets":["CFO John D. Morberg and James G. Hall will receive FY2024 incentive in fully vested, unrestricted shares instead of cash.","Number of Bonus Shares equals cash incentive amount divided by fair market value on determination date.","Shares issued under 2019 Stock Incentive Plan; if insufficient reserves, pro rata issuance with contingent shareholder approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001005286-24-000056","json":"https://secwatch.observer/filing/0001005286-24-000056.json","markdown":"https://secwatch.observer/filing/0001005286-24-000056.md","text":"https://secwatch.observer/filing/0001005286-24-000056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000056/0001005286-24-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000056/lndc-20240501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T15:17:01.744039+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}